NR4A1 and cancer: The effect size was also similar when analysis was repeated with just TNBC (aOR, 0.89; 95% CI, 0.85-0.93; P < .001) or just hormone receptor–positive cancers (aOR, 0.92; 95% CI, 0.86-0.98; P = .008).